Developer docs
API playgroundTry for free, no card

Search company profiles

Cornerstone Robotics

Full company profile

uuid0002tqk

Namestring
Cornerstone Robotics
Legal namestring
Cornerstone Robotics Limited
Websiteurl
csrbtx.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Cornerstone Robotics is a Hong Kong-headquartered surgical robotics company founded in September 2019 that develops full-stack endoscopic surgical robotic systems targeting the Chinese market and global expansion. The company's flagship product is the Sentire® Endoscopic Surgical Robotic System (C1000), which integrates in-house mechanical, electrical, software, algorithmic, and vision/imaging architectures (the underlying SRF platform) into a unified system covering urology, gynecology, general surgery, thoracic surgery, and hepato-biliary-pancreatic procedures. Complementary products include the CV2000 4K 3D endoscope (NMPA-registered with two certificates) and a portfolio of proprietary surgical instruments including 5mm micro wristed instruments and dual-force closure instruments. Technical differentiators include 600-degree wrist rotation, ultra-low latency master-slave control, active tremor filtration, immersive naked-eye 3D vision with 10x magnification, and AI-powered autonomous capabilities developed in collaboration with CUHK researchers.

The company operates a direct enterprise sales model selling capital equipment to hospitals through regional sales teams covering Hong Kong, mainland China (Beijing and Shanghai offices), Asia-Pacific, the UK (Portsmouth subsidiary established 2025), Europe, and globally. Revenue is generated through three streams: capital equipment sales (Sentire system and CV2000 endoscope), consumables and instruments, and after-sales service and professional training. Go-to-market is anchored by clinical KOL partnerships with leading academic hospitals, multi-regional regulatory approvals (NMPA September 2024, EU CE MDR May 2026, Singapore HSA May 2026), surgeon training programs at top institutions (CUHK, CUHK-Shenzhen, Portsmouth NHS Trust, NHG Singapore), and conference presence at EAU, CUA, and Medtec. Manufacturing is anchored by a 30,000-square-meter facility in Shenzhen's Greater Bay Area.

The company has raised over $270 million in disclosed funding across multiple rounds (cumulative across all rounds exceeds $475 million), achieving unicorn valuation, and has demonstrated clinical differentiation through milestone events including the world's first multi-site intercontinental robotic telesurgery across Shanghai-Hong Kong-London in July 2025 and the world's first clinical autonomous surgery verification published in Science Robotics in August 2025. Portsmouth Hospitals University NHS Trust has completed over 5,000 robotic procedures using the Sentire system, establishing a scalable NHS adoption model. Strategic investors include EQT (Series C lead), Hong Kong Investment Corporation (HKIC, November 2025 round lead), Qiming Venture Partners, Alpha JWC Ventures, and the Hong Kong SAR Government Innovation and Technology Venture Fund.

Short descriptiontext

Hong Kong-based surgical robotics company founded in 2019 developing the Sentire® Endoscopic Surgical Robotic System and CV2000 4K 3D endoscope for minimally invasive procedures across urology, gynecology, general, and thoracic surgery, with NMPA, EU CE MDR, and Singapore HSA approvals serving hospitals globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHong Kong, Hong Kong SAR China
HQ citystring
Hong Kong
HQ countrystring
Hong Kong SAR China
HQ regionstring
Asia
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
surgical robotics systems, endoscopic surgical robots, robotic-assisted surgery, laparoscopic surgical platforms, minimally invasive surgery devices
Industry4 codes
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHLAHADAB
Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Surgical Robotics
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Surgical Robotic System Sales (Capital Equipment)
TypeHardware Sales
Description

Sale of the Sentire Endoscopic Surgical System (C1000) and CV2000 4K 3D endoscope to hospitals. Direct enterprise sales model with regional sales teams in Hong Kong, Asia-Pacific, UK, Europe, and globally. Revenue recognized upon system installation and commissioning at customer sites.

equalocean.com
2Surgical Instruments and Consumables
TypeHardware Sales
Description

Sale of surgical instruments (long-life, flexible, multi-functional) that are consumed during procedures. The company produces and sells instrument sets compatible with the Sentire system. Additionally, consumables for the CV2000 endoscope system are sold alongside the hardware.

csrbtx.com
3After-Sales Service and Support
TypeProfessional Services
Description

After-sales technical support, maintenance, and professional education/training services. The company provides professional education programs for surgeons (online courses, simulator training, dry lab, animal lab, advanced courses) and surgical team training (operation training). Service hotline and email support are available regionally.

csrbtx.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure
Pricing details1 tier
1Sentire Endoscopic Surgical System — Enterprise Capital Purchase
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Direct enterprise sales to hospitals with pricing determined on a quote basis. No public list pricing available.

prnewswire.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Sentire思腾
Description

Endoscopic surgical robotic system brand; the company's flagship product featuring AI-powered autonomous capabilities for minimally invasive procedures across general surgery, gynecology, thoracic, and urology

csrbtx.com
+2 more records
Core offering1 text field

Cornerstone Robotics designs, manufactures, and sells the Sentire Endoscopic Surgical System (C1000), a full-stack minimally invasive surgical robotics platform for urology, gynecology, general surgery, and thoracic surgery. The company also sells the complementary CV2000 4K 3D electronic endoscope and proprietary wristed surgical instruments, and provides professional training and after-sales support services to hospitals and surgical teams globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Clinical trial success rate of 100% with no changes to surgical method or complications in mainland China multi-center trials (covering radical prostatectomy, partial nephrectomy, pyeloplasty)
+4 more records
Product overview1 text field

Cornerstone Robotics offers a unified surgical robotics platform anchored by the Sentire Endoscopic Surgical Robotic System (C1000), a flagship product for minimally invasive procedures. The portfolio includes the CV2000 4K 3D endoscope as a complementary imaging component and compatible surgical instruments. The system is indicated for general surgery, gynecology, thoracic surgery, and urology across China (NMPA), EU (CE Mark MDR), and Singapore (HSA).

Product and service4 records
1Sentire Endoscopic Surgical Robotic System (C1000)
CategorySurgical robotics system
Description

High-end surgical robotic platform combining clinical workflows with integrated engineering, software, and imaging technologies to support surgeons in performing complex minimally invasive procedures. Features 600° wrist rotation, 27L master workspace, 10x magnified immersive naked-eye 3D vision, dual-force closure feedback, ultra-low latency, active tremor filtration, anti-fog design, and integrated cold light source. Indicated for urology, gynecology, general surgery, and thoracic surgery. Sold to hospitals and surgical departments as capital equipment.

2CV2000 4K 3D Endoscope
CategorySurgical imaging system
Description

4K ultra-high definition 3D electronic thoracoscope and laparoscope with integrated image processing and lighting source. Features 3840x2160 resolution, intelligent noise reduction, auto white balance, auto light control, dual optical path true 3D, sapphire lens with soldered structure (IPX7 waterproof), and anti-fog design. Sells alongside the Sentire system as a complementary imaging component for hospitals.

3Sentire Surgical Instruments (5mm and 8mm Wristed Instruments)
CategoryRobotic surgical instruments and consumables
Description

Long-life, flexible, and durable surgical instruments compatible with the Sentire system, including proprietary 5mm and 8mm robotic instruments with 600° wrist articulation enabling access to narrow surgical spaces. Sold as instrument sets and consumables used during procedures.

4Professional Surgical Training and After-Sales Service Programs
CategoryProfessional training and support services
Description

Professional education programs for surgeons and clinical teams covering online courses, simulator training, dry lab, animal lab, and advanced courses, along with operation training for surgical teams. After-sales technical support, maintenance, and service hotline/email support are provided regionally. Sold to hospitals as part of system adoption and recurring service agreements.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
1National Healthcare Group (NHG) and Nanyang Technological University Singapore — Lee Kong Chian School of Medicine (LKCMedicine)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-17
Description

Cornerstone Robotics signed a tripartite MOU with NHG and NTU Singapore (LKCMedicine) in July 2025 to collaborate on robotic-assisted surgery clinical research, surgical education, and healthcare innovation. The partnership focuses on tele-surgical education and training research, and cost-effectiveness studies to facilitate extending RAS accessibility in Singapore. The MOU was witnessed by Singapore's Minister for Health Mr. Ong Ye Kung. In April 2026, the first Sentire system was installed at Woodlands Hospital under NHG for training and clinical workflow assessment.

en.csrbtx.com
2Renji Hospital of Shanghai Jiao Tong University
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-07-17
Description

Renji Hospital's surgical team (led by Prof. Zhang Zhizhen) participated in the world's first multi-site intercontinental robotic telesurgery (20,000 km, Shanghai-Hong Kong-London) using the Sentire system in July 2025. This collaboration demonstrates tele-surgical capability and positions the system for advanced clinical applications.

en.csrbtx.com
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-07-17
Description

Imperial College London's surgical team (led by Prof. Asif Chaudry, Hamlyn Centre) participated in the world's first multi-site intercontinental robotic telesurgery (Shanghai-Hong Kong-London) alongside Cornerstone's Sentire system. The Royal Marsden Hospital, a world-leading cancer center, collaborated on this landmark tele-surgical demonstration.

4Hamlyn Centre, Imperial College London
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-07-17
Description

The Hamlyn Centre at Imperial College London, a leading medical robotics research center, collaborated with Cornerstone and CUHK's InnoHK Multi-Scale Medical Robotics Center on the world's first multi-site intercontinental robotic telesurgery. This partnership combines world-class medical robotics research expertise with Cornerstone's surgical platform.

en.csrbtx.com
5InnoHK Multi-Scale Medical Robotics Center (MRC)
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-07-17
Description

The InnoHK Multi-Scale Medical Robotics Center, established at CUHK with government funding, is a global top-tier research laboratory. Cornerstone Robotics' founder Prof. Samuel Au serves as co-chair of this center. The collaboration focuses on clinical research, next-generation surgical robotics, and remote tele-surgical technology. Cornerstone completed multiple animal and cadaver experiments and clinical applications at this center.

en.csrbtx.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-30
Description

PHU partnered with Cornerstone Robotics in June 2025 to conduct the first formal clinical investigation of the Sentire Endoscopic Surgical System in the UK and Europe at Queen Alexandra Hospital. Led by Prof. Jim Khan, the trial covered colorectal and urological procedures. PHU is an international leader in surgical robotics with over 5,000 completed robotic procedures and the UK's first dedicated robotic-assisted day surgery program. This partnership provides European clinical data, regulatory validation, and a training base for UK/EU market entry.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-04-23
Description

Prof. Xue Li's team at Xi'an Jiaotong University Second Affiliated Hospital successfully performed a high-difficulty single-position multi-site malignancy surgery (kidney, ureter, bladder) using Cornerstone's surgical robot. This case validated the clinical performance of Cornerstone's system in complex urological procedures.

Strategic tierMinorTypeOthersAnnounced on2025-01-13
Description

UBS Group served as financial advisor for both the January 2025 Series C and the November 2025 ~US$200M financing rounds.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-06-07
Description

Cornerstone Robotics signed a strategic cooperation framework with CUHK-Shenzhen School of Medicine in June 2024 to jointly build a 'world-class minimally invasive surgery and surgical robot teaching base.' The partnership covers platform construction, educational training, and scientific research. This collaboration leverages the Greater Bay Area's manufacturing and AI capabilities to advance surgical robotics education and clinical application in southern China.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-08-01
Description

The Chinese University of Hong Kong Faculty of Medicine has partnered with Cornerstone since August 2022 for clinical trials of the Sentire system at Prince of Wales Hospital. Prof. Philip Chiu Wai-yan (Dean of CU Medicine) and Prof. Francis KL Chan led clinical collaborations. A December 2024 MOU expanded the partnership to include research, training, clinical applications, and next-generation robotic and remote tele-surgical technology development. The partnership leverages CUHK's InnoHK Multi-Scale Medical Robotics Center.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The global leader in surgical robotics with the da Vinci platform, dominating minimally invasive robotic surgery across urology, gynecology, general surgery, and thoracic. Direct competitor to Cornerstone's Sentire system in the same indications and hospital customer base, with the most entrenched installed base and surgeon training ecosystem.

TypeBroad incumbent
Description

Diversified medtech giant that has developed the Hugo robotic-assisted surgery platform targeting the same laparoscopic indications (urology, gynecology, general surgery) as Cornerstone's Sentire. Comparable as a direct robotic surgery competitor from a much larger incumbent with broader hospital relationships.

TypeDirect peer
Description

Chinese surgical robotics subsidiary of MicroPort Scientific developing the Toumai laparoscopic robotic system for similar urology, gynecology, thoracic, and general surgery indications. Direct domestic Chinese competitor with overlapping NMPA regulatory footprint and shared hospital target market.

TypeEmerging player
Description

China-based surgical robotics company developing endoscopic robotic platforms for minimally invasive surgery. Emerging direct peer in the Chinese surgical robotics competitive landscape with comparable technology profile and target indications.

TypeEmerging player
Description

Chinese surgical robotics developer focused on laparoscopic robotic systems. Comparable emerging Chinese peer competing for the same NMPA-approved robotic surgery market in urology, gynecology, and general surgery.

TypeEmerging player
Description

European-headquartered surgical robotics company developing a collaborative laparoscopic robotic platform. Comparable emerging competitor targeting the same minimally invasive surgical robotics space with focus on surgeon-friendly design.

TypeEmerging player
Description

Surgical robotics company developing the Senhance laparoscopic platform with digital surgery features. Comparable emerging competitor in robotic-assisted laparoscopic surgery targeting similar general surgery and gynecology indications.

8Johnson & Johnson (Ottava)
TypeBroad incumbent
Description

Healthcare conglomerate developing the Ottava multi-port robotic surgery platform as part of its broader medtech portfolio. Broad incumbent comparable due to overlapping robotic surgery strategy and vast hospital relationships, even as its platform is still pre-commercial.

TypeBroad incumbent
Description

Established orthopedic robotics leader with the Mako platform for joint replacement. Broad incumbent medtech comparable through shared surgical robotics DNA and hospital procurement channels, even though its primary focus is orthopedic rather than laparoscopic surgery.

TypeDirect peer
Description

UK-based surgical robotics company with the Versius laparoscopic robotic system approved for use across gynecology, general surgery, urology, and thoracic indications. Direct comparable peer competing for European hospital adoption with similar multi-specialty positioning to Cornerstone's Sentire.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors18 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cornerstone Robotics

Surgical Roboticscsrbtx.com

Hong Kong-based surgical robotics company founded in 2019 developing the Sentire® Endoscopic Surgical Robotic System and CV2000 4K 3D endoscope for minimally invasive procedures across urology, gynecology, general, and thoracic surgery, with NMPA, EU CE MDR, and Singapore HSA approvals serving hospitals globally.

What Cornerstone Robotics does

Cornerstone Robotics is a Hong Kong-headquartered surgical robotics company founded in September 2019 that develops full-stack endoscopic surgical robotic systems targeting the Chinese market and global expansion. The company's flagship product is the Sentire® Endoscopic Surgical Robotic System (C1000), which integrates in-house mechanical, electrical, software, algorithmic, and vision/imaging architectures (the underlying SRF platform) into a unified system covering urology, gynecology, general surgery, thoracic surgery, and hepato-biliary-pancreatic procedures. Complementary products include the CV2000 4K 3D endoscope (NMPA-registered with two certificates) and a portfolio of proprietary surgical instruments including 5mm micro wristed instruments and dual-force closure instruments. Technical differentiators include 600-degree wrist rotation, ultra-low latency master-slave control, active tremor filtration, immersive naked-eye 3D vision with 10x magnification, and AI-powered autonomous capabilities developed in collaboration with CUHK researchers.

The company operates a direct enterprise sales model selling capital equipment to hospitals through regional sales teams covering Hong Kong, mainland China (Beijing and Shanghai offices), Asia-Pacific, the UK (Portsmouth subsidiary established 2025), Europe, and globally. Revenue is generated through three streams: capital equipment sales (Sentire system and CV2000 endoscope), consumables and instruments, and after-sales service and professional training. Go-to-market is anchored by clinical KOL partnerships with leading academic hospitals, multi-regional regulatory approvals (NMPA September 2024, EU CE MDR May 2026, Singapore HSA May 2026), surgeon training programs at top institutions (CUHK, CUHK-Shenzhen, Portsmouth NHS Trust, NHG Singapore), and conference presence at EAU, CUA, and Medtec. Manufacturing is anchored by a 30,000-square-meter facility in Shenzhen's Greater Bay Area.

The company has raised over $270 million in disclosed funding across multiple rounds (cumulative across all rounds exceeds $475 million), achieving unicorn valuation, and has demonstrated clinical differentiation through milestone events including the world's first multi-site intercontinental robotic telesurgery across Shanghai-Hong Kong-London in July 2025 and the world's first clinical autonomous surgery verification published in Science Robotics in August 2025. Portsmouth Hospitals University NHS Trust has completed over 5,000 robotic procedures using the Sentire system, establishing a scalable NHS adoption model. Strategic investors include EQT (Series C lead), Hong Kong Investment Corporation (HKIC, November 2025 round lead), Qiming Venture Partners, Alpha JWC Ventures, and the Hong Kong SAR Government Innovation and Technology Venture Fund.

Cornerstone Robotics firmographics

Firmographics
Name
Cornerstone Robotics
Legal name
Cornerstone Robotics Limited
Website
https://csrbtx.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
Hong Kong-based surgical robotics company founded in 2019 developing the Sentire® Endoscopic Surgical Robotic System and CV2000 4K 3D endoscope for minimally invasive procedures across urology, gynecology, general, and thoracic surgery, with NMPA, EU CE MDR, and Singapore HSA approvals serving hospitals globally.
Ownership category
akta.pro rank

Cornerstone Robotics industry classification

Industry
Product category
Surgical Robotics
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHLAHADAB
Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment

Keywords

  • Surgical robotics systems
  • Endoscopic surgical robots
  • Robotic-assisted surgery
  • Laparoscopic surgical platforms
  • Minimally invasive surgery devices

Where Cornerstone Robotics is headquartered

Location

Headquarters

HQ city
Hong Kong
HQ country
Hong Kong SAR China
HQ region
Asia

Offices8 records

Markets served

Cornerstone Robotics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Surgical Robotic System Sales (Capital Equipment): Sale of the Sentire Endoscopic Surgical System (C1000) and CV2000 4K 3D endoscope to hospitals. Direct enterprise sales model with regional sales teams in Hong Kong, Asia-Pacific, UK, Europe, and globally. Revenue recognized upon system installation and commissioning at customer sites.
  2. Surgical Instruments and Consumables: Sale of surgical instruments (long-life, flexible, multi-functional) that are consumed during procedures. The company produces and sells instrument sets compatible with the Sentire system. Additionally, consumables for the CV2000 endoscope system are sold alongside the hardware.
  3. After-Sales Service and Support: After-sales technical support, maintenance, and professional education/training services. The company provides professional education programs for surgeons (online courses, simulator training, dry lab, animal lab, advanced courses) and surgical team training (operation training). Service hotline and email support are available regionally.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractSentire Endoscopic Surgical System — Enterprise Capital Purchase

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Cornerstone Robotics product offering

Product offering

Core offering

Cornerstone Robotics designs, manufactures, and sells the Sentire Endoscopic Surgical System (C1000), a full-stack minimally invasive surgical robotics platform for urology, gynecology, general surgery, and thoracic surgery. The company also sells the complementary CV2000 4K 3D electronic endoscope and proprietary wristed surgical instruments, and provides professional training and after-sales support services to hospitals and surgical teams globally.

Product overview

Cornerstone Robotics offers a unified surgical robotics platform anchored by the Sentire Endoscopic Surgical Robotic System (C1000), a flagship product for minimally invasive procedures. The portfolio includes the CV2000 4K 3D endoscope as a complementary imaging component and compatible surgical instruments. The system is indicated for general surgery, gynecology, thoracic surgery, and urology across China (NMPA), EU (CE Mark MDR), and Singapore (HSA).

Differentiator

Problem solved

Functional benefit

Brands

  • Sentire思腾: Endoscopic surgical robotic system brand; the company's flagship product featuring AI-powered autonomous capabilities for minimally invasive procedures across general surgery, gynecology, thoracic, and urology
  • CV2000
  • SRF

Products and services

  • Sentire Endoscopic Surgical Robotic System (C1000) High-end surgical robotic platform combining clinical workflows with integrated engineering, software, and imaging technologies to support surgeons in performing complex minimally invasive procedures. Features 600° wrist rotation, 27L master workspace, 10x magnified immersive naked-eye 3D vision, dual-force closure feedback, ultra-low latency, active tremor filtration, anti-fog design, and integrated cold light source. Indicated for urology, gynecology, general surgery, and thoracic surgery. Sold to hospitals and surgical departments as capital equipment.
  • CV2000 4K 3D Endoscope 4K ultra-high definition 3D electronic thoracoscope and laparoscope with integrated image processing and lighting source. Features 3840x2160 resolution, intelligent noise reduction, auto white balance, auto light control, dual optical path true 3D, sapphire lens with soldered structure (IPX7 waterproof), and anti-fog design. Sells alongside the Sentire system as a complementary imaging component for hospitals.
  • Sentire Surgical Instruments (5mm and 8mm Wristed Instruments) Long-life, flexible, and durable surgical instruments compatible with the Sentire system, including proprietary 5mm and 8mm robotic instruments with 600° wrist articulation enabling access to narrow surgical spaces. Sold as instrument sets and consumables used during procedures.
  • Professional Surgical Training and After-Sales Service Programs Professional education programs for surgeons and clinical teams covering online courses, simulator training, dry lab, animal lab, and advanced courses, along with operation training for surgical teams. After-sales technical support, maintenance, and service hotline/email support are provided regionally. Sold to hospitals as part of system adoption and recurring service agreements.

Quantifiable outcome

  • Clinical trial success rate of 100% with no changes to surgical method or complications in mainland China multi-center trials (covering radical prostatectomy, partial nephrectomy, pyeloplasty)
  • +4 more outcomes

Companies that use Cornerstone Robotics

Customer profile

Named customers9 records

Segments6 records

Ideal customer profiles3 records

Cornerstone Robotics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature8 records

Cornerstone Robotics partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core, major and minor.

  • National Healthcare Group (NHG) and Nanyang Technological University Singapore — Lee Kong Chian School of Medicine (LKCMedicine)coreStrategic or Co-development Partner · 17 July 2025Cornerstone Robotics signed a tripartite MOU with NHG and NTU Singapore (LKCMedicine) in July 2025 to collaborate on robotic-assisted surgery clinical research, surgical education, and healthcare innovation. The partnership focuses on tele-surgical education and training research, and cost-effectiveness studies to facilitate extending RAS accessibility in Singapore. The MOU was witnessed by Singapore's Minister for Health Mr. Ong Ye Kung. In April 2026, the first Sentire system was installed at Woodlands Hospital under NHG for training and clinical workflow assessment.
  • Renji Hospital of Shanghai Jiao Tong UniversitymajorStrategic or Co-development Partner · 17 July 2025Renji Hospital's surgical team (led by Prof. Zhang Zhizhen) participated in the world's first multi-site intercontinental robotic telesurgery (20,000 km, Shanghai-Hong Kong-London) using the Sentire system in July 2025. This collaboration demonstrates tele-surgical capability and positions the system for advanced clinical applications.
  • Imperial College London / The Royal Marsden HospitalmajorStrategic or Co-development Partner · 17 July 2025Imperial College London's surgical team (led by Prof. Asif Chaudry, Hamlyn Centre) participated in the world's first multi-site intercontinental robotic telesurgery (Shanghai-Hong Kong-London) alongside Cornerstone's Sentire system. The Royal Marsden Hospital, a world-leading cancer center, collaborated on this landmark tele-surgical demonstration.
  • Hamlyn Centre, Imperial College LondonmajorStrategic or Co-development Partner · 17 July 2025The Hamlyn Centre at Imperial College London, a leading medical robotics research center, collaborated with Cornerstone and CUHK's InnoHK Multi-Scale Medical Robotics Center on the world's first multi-site intercontinental robotic telesurgery. This partnership combines world-class medical robotics research expertise with Cornerstone's surgical platform.
  • InnoHK Multi-Scale Medical Robotics Center (MRC)coreTechnology or Integration · 17 July 2025The InnoHK Multi-Scale Medical Robotics Center, established at CUHK with government funding, is a global top-tier research laboratory. Cornerstone Robotics' founder Prof. Samuel Au serves as co-chair of this center. The collaboration focuses on clinical research, next-generation surgical robotics, and remote tele-surgical technology. Cornerstone completed multiple animal and cadaver experiments and clinical applications at this center.
  • Portsmouth Hospitals University NHS Trust (PHU)coreStrategic or Co-development Partner · 30 June 2025PHU partnered with Cornerstone Robotics in June 2025 to conduct the first formal clinical investigation of the Sentire Endoscopic Surgical System in the UK and Europe at Queen Alexandra Hospital. Led by Prof. Jim Khan, the trial covered colorectal and urological procedures. PHU is an international leader in surgical robotics with over 5,000 completed robotic procedures and the UK's first dedicated robotic-assisted day surgery program. This partnership provides European clinical data, regulatory validation, and a training base for UK/EU market entry.
  • Second Affiliated Hospital of Xi'an Jiaotong UniversitymajorStrategic or Co-development Partner · 23 April 2025Prof. Xue Li's team at Xi'an Jiaotong University Second Affiliated Hospital successfully performed a high-difficulty single-position multi-site malignancy surgery (kidney, ureter, bladder) using Cornerstone's surgical robot. This case validated the clinical performance of Cornerstone's system in complex urological procedures.
  • UBS Group (financial advisor)minorOthers · 13 January 2025UBS Group served as financial advisor for both the January 2025 Series C and the November 2025 ~US$200M financing rounds.
  • Chinese University of Hong Kong (Shenzhen) — School of MedicinecoreStrategic or Co-development Partner · 7 June 2024Cornerstone Robotics signed a strategic cooperation framework with CUHK-Shenzhen School of Medicine in June 2024 to jointly build a 'world-class minimally invasive surgery and surgical robot teaching base.' The partnership covers platform construction, educational training, and scientific research. This collaboration leverages the Greater Bay Area's manufacturing and AI capabilities to advance surgical robotics education and clinical application in southern China.
  • CUHK Faculty of Medicine / Prince of Wales HospitalcoreStrategic or Co-development Partner · 1 August 2022The Chinese University of Hong Kong Faculty of Medicine has partnered with Cornerstone since August 2022 for clinical trials of the Sentire system at Prince of Wales Hospital. Prof. Philip Chiu Wai-yan (Dean of CU Medicine) and Prof. Francis KL Chan led clinical collaborations. A December 2024 MOU expanded the partnership to include research, training, clinical applications, and next-generation robotic and remote tele-surgical technology development. The partnership leverages CUHK's InnoHK Multi-Scale Medical Robotics Center.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Cornerstone Robotics competitors and assessment

Company assessment

Direct peers

  • Intuitive Surgical: The global leader in surgical robotics with the da Vinci platform, dominating minimally invasive robotic surgery across urology, gynecology, general surgery, and thoracic. Direct competitor to Cornerstone's Sentire system in the same indications and hospital customer base, with the most entrenched installed base and surgeon training ecosystem.
  • MicroPort MedBot (Toumai): Chinese surgical robotics subsidiary of MicroPort Scientific developing the Toumai laparoscopic robotic system for similar urology, gynecology, thoracic, and general surgery indications. Direct domestic Chinese competitor with overlapping NMPA regulatory footprint and shared hospital target market.
  • CMR Surgical (Versius): UK-based surgical robotics company with the Versius laparoscopic robotic system approved for use across gynecology, general surgery, urology, and thoracic indications. Direct comparable peer competing for European hospital adoption with similar multi-specialty positioning to Cornerstone's Sentire.

Broad incumbents

  • Medtronic: Diversified medtech giant that has developed the Hugo robotic-assisted surgery platform targeting the same laparoscopic indications (urology, gynecology, general surgery) as Cornerstone's Sentire. Comparable as a direct robotic surgery competitor from a much larger incumbent with broader hospital relationships.
  • Johnson & Johnson (Ottava): Healthcare conglomerate developing the Ottava multi-port robotic surgery platform as part of its broader medtech portfolio. Broad incumbent comparable due to overlapping robotic surgery strategy and vast hospital relationships, even as its platform is still pre-commercial.
  • Stryker (Mako): Established orthopedic robotics leader with the Mako platform for joint replacement. Broad incumbent medtech comparable through shared surgical robotics DNA and hospital procurement channels, even though its primary focus is orthopedic rather than laparoscopic surgery.

Emerging players

  • Edge Medical Robotics: China-based surgical robotics company developing endoscopic robotic platforms for minimally invasive surgery. Emerging direct peer in the Chinese surgical robotics competitive landscape with comparable technology profile and target indications.
  • Shurui Robot: Chinese surgical robotics developer focused on laparoscopic robotic systems. Comparable emerging Chinese peer competing for the same NMPA-approved robotic surgery market in urology, gynecology, and general surgery.
  • Moon Surgical: European-headquartered surgical robotics company developing a collaborative laparoscopic robotic platform. Comparable emerging competitor targeting the same minimally invasive surgical robotics space with focus on surgeon-friendly design.
  • Asensus Surgical (Senhance): Surgical robotics company developing the Senhance laparoscopic platform with digital surgery features. Comparable emerging competitor in robotic-assisted laparoscopic surgery targeting similar general surgery and gynecology indications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Cornerstone Robotics social profiles

Digital presence

Cornerstone Robotics compliance and trust

Trust signal

Compliance3 records

Cornerstone Robotics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cornerstone Robotics leadership team

Management profile

Number of profiles

Profiles4 records

Cornerstone Robotics subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Cornerstone Robotics funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors18 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cornerstone Robotics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cornerstone Robotics

What does Cornerstone Robotics do?

Cornerstone Robotics designs, manufactures, and sells the Sentire Endoscopic Surgical System (C1000), a full-stack minimally invasive surgical robotics platform for urology, gynecology, general surgery, and thoracic surgery. The company also sells the complementary CV2000 4K 3D electronic endoscope and proprietary wristed surgical instruments, and provides professional training and after-sales support services to hospitals and surgical teams globally.

Is Cornerstone Robotics a public or private company?

Cornerstone Robotics is a private company. It is classified as venture growth investor backed and is currently operating.

When was Cornerstone Robotics founded?

Cornerstone Robotics was founded in 2019. It employs 1 to 10 people.

Where is Cornerstone Robotics based?

Cornerstone Robotics is headquartered in Hong Kong, Hong Kong SAR China, in the Asia region.

How does Cornerstone Robotics make money?

Three revenue lines are on record. Surgical Robotic System Sales (Capital Equipment) is the primary driver. The others are surgical Instruments and Consumables and after-Sales Service and Support.

Who are Cornerstone Robotics's main competitors?

Direct peers on record are Intuitive Surgical, MicroPort MedBot (Toumai) and CMR Surgical (Versius). Broad incumbents are Medtronic, Johnson & Johnson (Ottava) and Stryker (Mako). Emerging players are Edge Medical Robotics, Shurui Robot, Moon Surgical and Asensus Surgical (Senhance).

Does Cornerstone Robotics have an API?

No public API is recorded for Cornerstone Robotics.

What industry is Cornerstone Robotics in?

Cornerstone Robotics's product category is Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HDAAAIAC, Healthcare & Assistive Robotics. Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business & FinancialCornerstone Robotics Hosts Inaugural 'Surgical Futures Forum', Global Leaders Gather In Hong Kong To Chart The Next Frontier Of Accessible Surgical Care Through Robotics & InnovationCornerstone Robotics hosted its inaugural Surgical Futures Forum in Hong Kong, bringing together global leaders to discuss accessible surgical care. Medtronic made a strategic investment of approximately $700 million and secured distribution rights to Cornerstone's Sentire surgical system. The partnership aims to expand access to robotic-assisted surgery worldwide.ACN NewswireCornerstone Robotics Hosts Inaugural 'Surgical Futures Forum', Global Leaders Gather in Hong Kong to Chart the Next Frontier of Accessible Surgical Care Through Robotics & InnovationCornerstone Robotics hosted its inaugural Surgical Futures Forum in Hong Kong, bringing global leaders to discuss accessible surgical care. Medtronic invested approximately $700 million and secured distribution rights to Cornerstone's Sentire surgical system. The partnership aims to expand access to robotic-assisted surgery worldwide.Insider Trading & Hedge Fund DataCan Medtronic’s (MDT) Core Units Keep Up With Management’s New Bets?Medtronic revised its fiscal 2027 organic revenue growth outlook to 7.25-7.75%, up from 6.75-7.25%, citing strength in core segments and momentum in growth areas. The company also announced a $700 million partnership with Cornerstone Robotics for distribution rights to Sentire Surgical System. Competitors like Johnson & Johnson and Intuitive Surgical pose challenges in targeted markets.YahooJim Cramer Calls Medtronic (MDT) a “Quandary” as Growth Surges and Diabetes Exit NearsMedtronic reported fiscal Q1 2027 revenue of nearly $9.8 billion, up 13.7% organically, and raised its full-year growth forecast. Jim Cramer called the company a "quandary" as it plans to exit its diabetes division by year-end. The company also raised its EPS guidance and invested in Cornerstone Robotics.Simply Wall StIs Medtronic’s US$700 Million Robotics Push With Cornerstone Reshaping The Investment Case For MDT?Medtronic reported Q1 2026 sales of $9.756 billion and net income of $1.47 billion, and announced a roughly $700 million partnership with Cornerstone Robotics to distribute the Sentire surgical system alongside its Hugo platform outside the U.S. The deal expands its robotic-assisted surgery offering, which could amplify execution risks in its robotics pipeline.TodaysmedicaldevelopmentsMedtronic announces partnerships, investments with Cornerstone Robotics and Pi-CardiaMedtronic announced a partnership with Cornerstone Robotics, investing about $700 million to distribute the Sentire surgical system outside the U.S. and an investment in Pi-Cardia up to $80 million for its ShortCut leaflet modification device. Medtronic will become the exclusive global distributor of ShortCut in 2027, with an option to acquire Pi-Cardia for up to $210 million.TherobotreportMedtronic invests $700M in surgical partner Cornerstone RoboticsMedtronic announced a $700 million investment in Cornerstone Robotics and gained rights to distribute its Sentire surgical system in select non-U.S. markets. The partnership expands Medtronic's Hugo robotic-assisted surgery platform, with Sentire approved in China, the EU, and Singapore. Medtronic expects Hugo procedures to exceed 50,000 globally by fiscal year end.Med-Tech InsightsMedtronic Backs Cornerstone Robotics in $700M Distribution DealMedtronic announced a strategic partnership with Cornerstone Robotics, investing approximately $700 million for distribution rights to the Sentire surgical system in select non-U.S. markets. The deal is not an acquisition, with Cornerstone retaining ownership of the platform and intellectual property. Medtronic will distribute Sentire alongside its Hugo robotic-assisted surgery system.BioWorldMedtronic expands investment ecosystem with $780M in new dealsMedtronic committed $780 million in new deals, including $700 million in Cornerstone Robotics, which includes rights to distribute the Sentire surgical system in select markets outside the U.S. The investment comes despite Medtronic's own Hugo robotic-assisted surgery platform.FinSMEsCornerstone Robotics Receives US$700M Strategic Investment from MedtronicMedtronic invested US$700 million in Cornerstone Robotics, a Hong Kong surgical robotics firm, in a strategic partnership. Medtronic will distribute Cornerstone's Sentire system in select markets outside the U.S. where it is approved, including China, the EU, and Singapore.